Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis
Elena Tsantes, Erica Curti, Filippo Collura, Veronica Bazzurri, Alessia Fiore, Franco Granella
Topics & Concepts
MedicineMultiple sclerosisInternal medicineSurrogate endpointExpanded Disability Status ScalePredictive valueDiseaseRelapsing remittingGastroenterologyImmunologyMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesViral Infections and Immunology Research